Answers are grounded in this paper and cite their sources.
Purpose Radiolabeled nanoparticles (NPs) are investigated for preclinical imaging and nano-brachytherapy, where accurate in vivo localization is essential. Here, we present a benchtop 2D multi-pinhole X-ray imaging system for characteristic X-ray imaging using an energy-resolving 2 × 2 cadmium zinc telluride detector. Procedures Polyethylene glycol (PEG)-coated iodine-125 ( 125 I)-labeled gold (Au) core and silver (Ag) shell NPs (PEG- 125 I-Au@Ag NPs) were used. The multi-pinhole X-ray imaging system was calibrated using PEG- 125 I-Au@Ag NP-containing solutions, and the activity threshold was estimated. Three CT26 tumor-bearing BALB/c mice received intratumoral injections of 500 μCi PEG- 125 I-Au@Ag NPs. In vivo imaging was performed with 10-min scan times at 0, 3, 6, 24, 96, and 120 h post-injection, followed by endpoint ex vivo imaging of the excised tumor and major organs. Results The multi-pinhole X-ray imaging system showed linearity between activity and characteristic X-ray photon counts with R 2 = 0.9992, and the extrapolated activity threshold was 0.05 μCi. In vivo imaging tracked intratumoral retention kinetics, showing a marked decline within 24 h followed by a slower phase through 120 h. Endpoint ex vivo imaging supported sustained intratumoral retention at T = 120 h, with 26.41 ± 2.09% of the injected dose and 202.35 ± 98.83% of the injected dose per gram retained in the tumor. The liver activity was 1.17 ± 0.80% of the injected dose and 0.82 ± 0.64% of the injected dose per gram, whereas the thyroid activity was 1.92 ± 0.15% of the injected dose and 97.94 ± 20.11% of the injected dose per gram. The difference between in vivo and ex vivo measurements ranged from 0.03 to 3.51 μCi, with relative percent differences of 0.74% to 12.80%. Conclusions The multi-pinhole X-ray imaging system enables semi-quantitative assessment of intratumoral retention and biodistribution of PEG- 125 I-Au@Ag NPs in the measured organs, providing a practical approach for longitudinal preclinical evaluation.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: